The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China
Abstract Background During the coronavirus disease 2019 (COVID-19) epidemic, due to the traffic blockade and the shortage of medical resources, more and more premature infants could not receive timely and effective ROP screening, which delayed treatment and even caused children blindness. Therefore,...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12886-021-02018-x |
_version_ | 1818440914777931776 |
---|---|
author | Zheng Guo Nan Ma Yixuan Wu Hua Yuan Wanjun Luo Lingkong Zeng Hong Jie Shilian Li |
author_facet | Zheng Guo Nan Ma Yixuan Wu Hua Yuan Wanjun Luo Lingkong Zeng Hong Jie Shilian Li |
author_sort | Zheng Guo |
collection | DOAJ |
description | Abstract Background During the coronavirus disease 2019 (COVID-19) epidemic, due to the traffic blockade and the shortage of medical resources, more and more premature infants could not receive timely and effective ROP screening, which delayed treatment and even caused children blindness. Therefore, how to carry out ROP screening safely and effectively during the epidemic was very important and urgent. This study aimed to evaluate the safety and feasibility of ROP screening assisted by telemedicine network during COVID-19 outbreak. Methods This retrospective study was conducted at Wuhan Children’s hospital in Wuhan, China, from January to October, 2020. The measures which were performed to make the ROP screening more safe and effective were summarized and the comparison between ROP screening assisted by telemedicine network in 2020 and usual screening in 2019 were analyzed. Results A total of 267 outpatient infants completed ROP screening. The median gestational age was 32 weeks (30w to 34w) and the median birth weight was 1780 g (1460 g to 2100 g). Meanwhile, 149 (55.8%) out of 267 infants were males. During January to May in 2020, 86 screening appointments were received, among which 67 (77.9%) were from telemedicine platform online. The completing percentage of total online ROP appointments was higher than that of total face-to-face appointments (58.1% VS 22. 1%, P = 0.018). As for the number of infants screened between 2020 and 2019 from Februaryto October, 54 infants completed ROP screening in 2020, which was higher than that (51participants) in 2019 on September. Furthermore, compared with the usual screening in 2019, ROP screening assisted by telemedicine network in 2020 had smaller gestational age (32w VS 33w, p<0.001) and lower birth weight (1780 g VS 1900 g, p = 0.001). However, of the 267 infants screened, 18(6.7%) had ROP while the percentage of ROP screened in 2019 was the same (44[6.7%]). During follow-up, none of medical staffs was infected and no adverse reaction was reported. Conclusions The screening for retinopathy of prematurity assisted by telemedicine network was safe and feasible during the COVID-19 pandemic. Preventive measures before and after screening were very necessary, which could effectively avoid cross infection. |
first_indexed | 2024-12-14T18:19:56Z |
format | Article |
id | doaj.art-d0ef6d35019a4d05afb8543a0ae5d945 |
institution | Directory Open Access Journal |
issn | 1471-2415 |
language | English |
last_indexed | 2024-12-14T18:19:56Z |
publishDate | 2021-06-01 |
publisher | BMC |
record_format | Article |
series | BMC Ophthalmology |
spelling | doaj.art-d0ef6d35019a4d05afb8543a0ae5d9452022-12-21T22:52:06ZengBMCBMC Ophthalmology1471-24152021-06-012111810.1186/s12886-021-02018-xThe safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, ChinaZheng Guo0Nan Ma1Yixuan Wu2Hua Yuan3Wanjun Luo4Lingkong Zeng5Hong Jie6Shilian Li7Department of Ophthalmology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Medical College, Huazhong University of Science & TechnologyDepartment of Ophthalmology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Medical College, Huazhong University of Science & TechnologyDepartment of Ophthalmology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Medical College, Huazhong University of Science & TechnologyDepartment of Ophthalmology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Medical College, Huazhong University of Science & TechnologyDepartment of infection management, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & TechnologyDepartment of neonatology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & TechnologyDepartment of Ophthalmology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Medical College, Huazhong University of Science & TechnologyDepartment of Ophthalmology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Medical College, Huazhong University of Science & TechnologyAbstract Background During the coronavirus disease 2019 (COVID-19) epidemic, due to the traffic blockade and the shortage of medical resources, more and more premature infants could not receive timely and effective ROP screening, which delayed treatment and even caused children blindness. Therefore, how to carry out ROP screening safely and effectively during the epidemic was very important and urgent. This study aimed to evaluate the safety and feasibility of ROP screening assisted by telemedicine network during COVID-19 outbreak. Methods This retrospective study was conducted at Wuhan Children’s hospital in Wuhan, China, from January to October, 2020. The measures which were performed to make the ROP screening more safe and effective were summarized and the comparison between ROP screening assisted by telemedicine network in 2020 and usual screening in 2019 were analyzed. Results A total of 267 outpatient infants completed ROP screening. The median gestational age was 32 weeks (30w to 34w) and the median birth weight was 1780 g (1460 g to 2100 g). Meanwhile, 149 (55.8%) out of 267 infants were males. During January to May in 2020, 86 screening appointments were received, among which 67 (77.9%) were from telemedicine platform online. The completing percentage of total online ROP appointments was higher than that of total face-to-face appointments (58.1% VS 22. 1%, P = 0.018). As for the number of infants screened between 2020 and 2019 from Februaryto October, 54 infants completed ROP screening in 2020, which was higher than that (51participants) in 2019 on September. Furthermore, compared with the usual screening in 2019, ROP screening assisted by telemedicine network in 2020 had smaller gestational age (32w VS 33w, p<0.001) and lower birth weight (1780 g VS 1900 g, p = 0.001). However, of the 267 infants screened, 18(6.7%) had ROP while the percentage of ROP screened in 2019 was the same (44[6.7%]). During follow-up, none of medical staffs was infected and no adverse reaction was reported. Conclusions The screening for retinopathy of prematurity assisted by telemedicine network was safe and feasible during the COVID-19 pandemic. Preventive measures before and after screening were very necessary, which could effectively avoid cross infection.https://doi.org/10.1186/s12886-021-02018-xRetinopathy of prematurityScreeningCOVID-19Telemedicine |
spellingShingle | Zheng Guo Nan Ma Yixuan Wu Hua Yuan Wanjun Luo Lingkong Zeng Hong Jie Shilian Li The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China BMC Ophthalmology Retinopathy of prematurity Screening COVID-19 Telemedicine |
title | The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China |
title_full | The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China |
title_fullStr | The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China |
title_full_unstemmed | The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China |
title_short | The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China |
title_sort | safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during covid 19 pandemic in wuhan china |
topic | Retinopathy of prematurity Screening COVID-19 Telemedicine |
url | https://doi.org/10.1186/s12886-021-02018-x |
work_keys_str_mv | AT zhengguo thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT nanma thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT yixuanwu thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT huayuan thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT wanjunluo thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT lingkongzeng thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT hongjie thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT shilianli thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT zhengguo safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT nanma safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT yixuanwu safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT huayuan safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT wanjunluo safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT lingkongzeng safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT hongjie safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina AT shilianli safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina |